Finance

Beta
Lists
CLRB:NASDAQ
Cellectar Biosciences Inc
$2.78
+6.92%
(+0.18) 1D
$2.79
+0.36% (+0.0100)
After hours
Closed: Jun 30, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLRB...
Open
$2.59
High
$3.08
Low
$2.55
Mkt. cap
22.22M
Avg. vol.
174.93K
Volume
415.82K
52-wk high
$6.52
52-wk low
$2.20
EPS
-$7.41
Beta
0.52
Shares outstanding
7.99M
No. of employees
11
Open
$2.59
High
$3.08
Low
$2.55
Mkt. cap
22.22M
Avg. vol.
174.93K
Volume
415.82K
52-wk high
$6.52
52-wk low
$2.20
EPS
-$7.41
Beta
0.52
Shares outstanding
7.99M
No. of employees
11
News stories
From sources across the web
About Cellectar Biosciences Inc
CEO-
Employees11
Founded1996
HeadquartersFlorham Park, New Jersey, United States
SectorBiotechnology
Websitecellectar.com
Analyst ratings
Based on 3 analysts giving stock ratings to CLRB in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for CLRB in the last 3 months.
Highest
Current $2.78
$11.00 (+295.68%)
Average
$10.33 (+271.58%)
Lowest
$10.00 (+259.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
$10.00
+259.7%
05/15/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$10.00
+259.7%
05/15/2026
Jonathan Aschoff
Roth MKM
Buy
Reiterated
$11.00
+295.7%
05/05/2026
Jeff Jones
Oppenheimer
Hold
Maintained
-
-
11/14/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.39M
2.52M
3.16M
3.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.65M
2.33M
2.53M
2.79M
Operating expense
6.04M
4.85M
5.69M
5.79M
Total operating expenses
6.04M
4.85M
5.69M
5.79M
Operating income
-6.04M
-4.85M
-5.69M
-5.79M
Other non operating income
501.60K
294.28K
297.83K
77.00K
EBT including unusual items
-5.45M
-4.44M
-5.30M
-5.65M
EBT excluding unusual items
-5.45M
-4.44M
-5.30M
-5.65M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.45M
-4.44M
-5.30M
-5.65M
Net profit margin
-
-
-
-
Earnings per share
-3.39
-1.41
-0.53
-1.33
Interest and investment income
88.02K
112.54K
97.58K
63.00K
Interest expense
-
-
-
-
Net interest expenses
88.02K
112.54K
97.58K
63.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.98M
-4.80M
-5.64M
-5.74M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer